49 results
Page 3 of 3
424B5
if6xv7vj9rgxx8
4 Apr 19
Prospectus supplement for primary offering
4:13pm
8-K
EX-10.1
vi120rzhs7ums53mayvy
11 Jan 19
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-99.1
cfc8omxlkgavwoyixjw
3 Dec 18
Syros Announces Promising Clinical Data from Ongoing Phase 2 Trial of SY-1425 in Genomically Defined AML and MDS Patients at ASH Annual Meeting
8:07am
8-K
EX-99.1
jnu16okf
15 Nov 18
Regulation FD Disclosure
4:03pm
10-K
5gkv269
20 Mar 17
Annual report
12:00am